Nuvation Bio Inc. Class A Common Stock vs Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B), while Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) trades at $25.04 (market cap $156.97B). The key difference: Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) is far larger — about 90.2× Nuvation Bio Inc. Class A Common Stock's market cap, and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) pays a 2.34% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) for 1 Days on average.
| NUVB | SMFG | |
|---|---|---|
Market Cap | $1.74B | $156.97B |
Volume | 9,289,619 | 1,237,125 |
Sector | Health | Financials |
52-Week High | $9.54 | $27.56 |
52-Week Low | $3.41 | $15.20 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $1.33B | $12.48T |
Dividend Yield | — | 2.34% |
Trailing returns across standard periods
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →Sumitomo Mitsui Financial Group is a Japanese financial services company with banking, securities, leasing, and asset management businesses. It serves retail, corporate, and institutional clients.
Read more on SMFG →